C6ORF62 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 1.21350000004128E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
2.100300E-02
Normal-vs-Stage2
1.56210000001877E-06
Normal-vs-Stage3
2.299900E-02
Normal-vs-Stage4
5.836000E-02
Stage1-vs-Stage2
5.277400E-01
Stage1-vs-Stage3
2.394000E-01
Stage1-vs-Stage4
9.371400E-01
Stage2-vs-Stage3
3.597800E-01
Stage2-vs-Stage4
6.759600E-01
Stage3-vs-Stage4
3.591200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
2.28390000001077E-06
Normal-vs-AfricanAmerican
1.324620E-01
Normal-vs-Asian
1.302220E-03
Caucasian-vs-AfricanAmerican
7.445000E-01
Caucasian-vs-Asian
2.925400E-01
AfricanAmerican-vs-Asian
3.079600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
3.30820000005172E-06
Normal-vs-Female
1.257580E-01
Male-vs-Female
1.553030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
7.976300E-02
Normal-vs-Age(41-60Yrs)
1.262790E-01
Normal-vs-Age(61-80Yrs)
4.57750000004697E-06
Normal-vs-Age(81-100Yrs)
1.359210E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.887800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.239800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.895600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.211600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.836200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.727800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
5.5351999999953E-05
Normal-vs-Daily Drinker
4.24490000000555E-05
Normal-vs-Weekly Drinker
1.177980E-01
Normal-vs-Occasional Drinker
6.584000E-04
Normal-vs-Social Drinker
1.536360E-03
Non Drinker-vs-Daily Drinker
6.702000E-01
Non Drinker-vs-Weekly Drinker
4.537000E-01
Non Drinker-vs-Occasional Drinker
4.544600E-01
Non Drinker-vs-Social Drinker
1.493600E-01
Daily Drinker-vs-Weekly Drinker
2.513600E-01
Daily Drinker-vs-Occasional Drinker
2.679600E-01
Daily Drinker-vs-Social Drinker
7.338300E-02
Weekly Drinker-vs-Occasional Drinker
9.936800E-01
Weekly Drinker-vs-Social Drinker
4.833800E-01
Occasional Drinker-vs-Social Drinker
5.058600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
4.650800E-01
Normal-vs-Grade 2
7.358800E-01
Normal-vs-Grade 3
7.725200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.909800E-01
Grade 1-vs-Grade 3
9.317600E-01
Grade 1-vs-Grade 4
4.650800E-01
Grade 2-vs-Grade 3
4.681800E-01
Grade 2-vs-Grade 4
7.358800E-01
Grade 3-vs-Grade 4
7.725200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
2.193800E-04
Normal-vs-NonDiabetic
1.085000E-01
Diabetic-vs-NonDiabetic
3.457200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
8.117800E-02
Normal-vs-NoPancreatitis
1.33989999995254E-06
Pancreatitis-vs-NoPancreatitis
6.242800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
4.00150000000599E-05
Normal-vs-N1
1.53719999995694E-06
N0-vs-N1
9.494600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
1.366200E-01
Normal-vs-TP53-NonMutant
2.015400E-01
TP53-Mutant-vs-TP53-NonMutant
3.175900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap